These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 20577000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Liver dysfunction in patients with IBD under immunosuppressive treatment: do we need to fear?
    Beaugerie L, Gerbes AL.
    Gut; 2010 Oct; 59(10):1310-1. PubMed ID: 20833661
    [No Abstract] [Full Text] [Related]

  • 5. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.
    Gisbert JP, Chaparro M, Esteve M.
    Aliment Pharmacol Ther; 2011 Mar; 33(6):619-33. PubMed ID: 21416659
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
    Waszczuk E, Waszczuk KM, Mulak A, Paradowski L.
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):628-32. PubMed ID: 26904976
    [Abstract] [Full Text] [Related]

  • 10. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
    Faggioli P, De Paschale M, Tocci A, Luoni M, Fava S, De Paoli A, Tosi A, Cassi E.
    Haematologica; 1997 Jun; 82(1):38-42. PubMed ID: 9107080
    [Abstract] [Full Text] [Related]

  • 11. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.
    Piaserico S, Messina F, Russo FP.
    Am J Clin Dermatol; 2019 Dec; 20(6):829-845. PubMed ID: 31222626
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.
    Degasperi E, Caprioli F, El Sherif O, Back D, Colombo M, Aghemo A.
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1373-1383. PubMed ID: 27718758
    [Abstract] [Full Text] [Related]

  • 14. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.
    Stroffolini T, Sagnelli E, Sagnelli C, Smedile A, Furlan C, Morisco F, Coppola N, Andriulli A, Almasio PL.
    Dig Liver Dis; 2019 Mar; 51(3):434-437. PubMed ID: 30361062
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
    Khattab E, Chemin I, Vuillermoz I, Vieux C, Mrani S, Guillaud O, Trepo C, Zoulim F.
    J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Murugavel KG, Balakrishnan P, Kumarasamy N, Solomon S, Thyagarajan SP.
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.